Latest Asia Pacific News

SEEK Limited delivered solid operational growth with record dividends in FY2026, yet posted a hefty net loss driven by a $284m impairment on its Chinese associate Zhaopin and a $201m loss from its Growth Fund.

Sprintex has inked a co-development deal with Jiangsu Bosiwei to supply its 30kW MVR compressors for a major retrofit at Hebei Yufeng Group, marking its strategic entry into China’s booming industrial vapor compression market.

Chrysos Corporation posted a 33% revenue increase and 68% EBITDA growth in FY26, driven by expanding its PhotonAssay™ technology fleet to 46 units worldwide and signing 24 new lease agreements.

LTR Pharma reports a 93% response rate in men seeking convenience and spontaneity with SPONTAN, alongside a 64% response in post-prostatectomy patients, highlighting potential for its rapid-onset intranasal ED treatment in challenging populations.

Senetas Corporation has returned $3.5 million to shareholders through an equal capital reduction, distributing $0.2111 per share following shareholder approval in July 2026.

ReNerve has secured marketing approval for its NervAlign® Nerve Cuff in the Philippines, tapping into a major Southeast Asian market with significant nerve injury demand.

NH3 Clean Energy has raised $4 million through a private placement priced at an 18.4% discount to fund front-end engineering and design work for its WAH2 clean ammonia project, signalling strong institutional backing as it approaches key development milestones.

Ava Risk Group has appointed Bryant Henson as CEO to spearhead its next growth phase, with a sharp focus on expanding its footprint in the United States and strengthening commercial execution worldwide.

Advanced Innergy Holdings (ASX:AIH) has revised down its FY26 revenue and EBITDA forecasts due to project timing delays and supply chain issues but maintains a robust order book and financial position.

Jade Gas Holdings has secured regulatory approvals for Mongolia’s first coal bed methane reserves, completed a A$12 million capital raise, and signed a non-binding A$1.1 billion collaboration agreement to fund initial development of its Red Lake gasfield.

OpenLearning Limited posted a record $3.27 million in SaaS annual recurring revenue and its highest quarterly cash receipts of $1.653 million, driven by new multi-year contracts in the Philippines and Malaysia and launches of AI-driven student recruitment and employability platforms.

Island Pharmaceuticals has marked a major step forward in its antiviral program with the start of GMP manufacturing for Galidesivir, expanded USAMRIID collaboration, and FDA orphan drug designation. Regulatory approvals for compassionate use in Uganda’s Ebola outbreak and a new dose optimisation study with Texas Biomed further de-risk the pathway to approval.